Home » Topics » Regulatory » Patents

Patents
RSS

Anticancer imidazoles from Merck & Co.

March 9, 1998

Xanthene derivatives useful for neurodegenerative disorders

March 6, 1998

Pharmacia & Upjohn presents new tyrosine kinase inhibitors

March 6, 1998

HMR prepares new antibacterial agents for Gram-positive infections

March 6, 1998

Astra develops new gastric antisecretory agents

March 6, 1998

Antitumor agents isolated from fungal strains by Roche

March 6, 1998

Succinamide derivatives for inhibiting MMPs and/or TNF production

March 6, 1998

Purdue discloses antitumor selenophene compounds

March 5, 1998

New antiinflammatory and analgesic compounds in development at Roche

March 5, 1998

Cell adhesion inhibitors described by Kyowa Hakko

March 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.